Podcasts about europcr

In the latest JACC offering from EuroPCR, JACC Associate Editor Celina M. Yong, MD, FACC, interviews Dr. Ashkan Eftekhari, PhD, to discuss insights into his study, Biolimus-Eluting Biomatrix Stent Versus a Dual-Therapy Sirolimus-Eluting Stent in PCI: SORT OUT XI Randomized Trial. The biolimus A9-eluting BioMatrix Alpha stent (BES), has not been compared with another contemporary drug eluting stent. This study compared one-year target lesion failure (TLF) in BES versus the dual-therapy sirolimus-eluting Combo stent (DTS) in an all-comer population undergoing PCI. A total of 3,136 patients were randomized 1:1 to either BES or DTS. The primary result showed that BES was non-inferior to DTS. Additionally, there was a significantly higher rate of definite stent thrombosis in the BES arm. In conclusion, BES was non-inferior to DTS at one-year follow-up with respect to the primary endpoint, TLF.

JACC Executive Associate Editor Karthik Murugiah, MD, FACC, speaks with author Jasmine M. Marquard, MD, PhD, on her study published in JACC and presented at EuroPCR. The discussion focuses on 10-year outcomes, including repeated events, of fractional flow reserve (FFR)-guided complete revascularization versus treatment of the infarct-related artery only in ST-segment elevation myocardial infarction. As the original trial, the primary outcome was a composite of all-cause mortality, recurrent myocardial infarction, or any revascularization. Complete revascularization reduced the risk of the primary outcome by 24%. Complete re-vascularization showed an absolute reduction of 13 events (-1 to 28 events) per 100 persons after 10 years. FFR-guided complete revascularization reduced future and repeated events after 10 years, primarily by reducing revascularization rates, without reducing myocardial infarctions or death.

Roxana Mehran hears a preview of what's in store from Nieves Gonzalo and Thomas Cuisset.

Dear folks, we have uploaded the English edition of euroPCR 2024, we hope you will enjoy listening to this episode. You can also download the slides via this link:http://ecardiocast.com/wp-content/uploads/2024/06/PCR2024.pdf

Dear friends, we are back with the summary of the trials of euroPCR 2024 and you can also download the summary of trials with the following link. we hope you will enjoy listening to this episode.http://ecardiocast.com/wp-content/uploads/2024/06/PCR2024.pdf

Host Shelley Wood sums up some top news from SCAI, ESC-HF, ESOC, HRS, and EuroPCR, with takeaways from Thomas Cuisset.

Roxana Mehran gets an early look at what's ahead in Paris from Nicolas Dumonteil and Thomas Cuisset.

Dear folks, the English edition of the Coronary Intravascular imaging meta-analysis episode is uploaded and we believe you will enjoy listening to this episode. You can also download the slides via the following link:http://ecardiocast.com/wp-content/uploads/2024/04/IVI.pdf

Dear friends and colleagues, in this touching episode, we discussed a network meta-analysis on intravascular imaging (IVI) and its role in 2024, we hope you will enjoy listening to this episode. You can also download the slides via the following link:http://ecardiocast.com/wp-content/uploads/2024/04/IVI.pdf

Dear folks, as we have promised, we prepared the English summary of the euroPCR 2023 and we hope you will give us feedback as always. enjoy listening to this episode.

Dear folks, we have prepared a summary of trials presented at EuroPCR 2023, we hope you will enjoy this episode.

Host Shelley Wood catches up with Davide Capodanno and Sunil Rao to hear their highlights from these meetings.

Roxana Mehran gets a preview of the 2023 meeting from its three new course directors: Thomas Cuisset, Nicolas Dumonteil, and Nieves Gonzalo.

Dear Friends, as in our previous episodes, we have prepared a summary of the latest trials presented at euroPCR 2022, we hope you enjoy listening to this episode and you can visit the website for more information :http://ecardiocast.com/europcr-2022-wrap-up/

Dear Friends, as in our previous episodes, we have prepared a summary of the latest trials presented at euroPCR 2022, we hope you enjoy listening to this episode and you can visit the website for more information :http://ecardiocast.com/europcr-2022-wrap-up/

The Beat episode, hosted by Patrick Myers, cardiac surgeon at the University of Lausanne and Geneva, Switzerland, focuses on three recent publications, presented at the ACC21 and EuroPCR meetings. First, Dr Myers discusses the LAAOS III trial, a practice-changing multicenter prospective randomized trial of left atrial appendage occlusion during cardiac surgery. He then dives into a meta-analysis comparing revascularization and medical treatment, covering 20'000 patients from 25 RCTs. Dr Myers then reviews a UK study on the impact of the COVID-19 pandemic on SAVR and TAVI volumes. He finally notes to not miss the guest editor series lead by Mark Gerdish, on surgery for atrial fibrillation. For more information on this episode's topics, links to the articles are provided below: 1. Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, Reents W, Budera P, Baddour AJ, Fila P, Devereaux PJ, Bogachev-Prokophiev A, Boening A, Teoh KHT, Tagarakis GI, Slaughter MS, Royse AG, McGuinness S, Alings M, Punjabi PP, Mazer CD, Folkeringa RJ, Colli A, Avezum Á, Nakamya J, Balasubramanian K, Vincent J, Voisine P, Lamy A, Yusuf S, Connolly SJ; LAAOS III Investigators. Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke. N Engl J Med. 2021 May 15. doi: 10.1056/NEJMoa2101897. 2. Navarese EP, Lansky AJ, Kereiakes DJ, Kubica J, Gurbel PA, Gorog DA, Valgimigli M, Curzen N, Kandzari DE, Bonaca MP, Brouwer M, Umińska J, Jaguszewski MJ, Raggi P, Waksman R, Leon MB, Wijns W, Andreotti F. Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis. Eur Heart J. 2021 May 18:ehab246. doi: 10.1093/eurheartj/ehab246. 3. Martin GP, Curzen N, Goodwin AT, Nolan J, Balacumaraswami L, Ludman PF, Kontopantelis E, Wu J, Gale CP, de Belder MA, Mamas MA. Indirect Impact of the COVID-19 Pandemic on Activity and Outcomes of Transcatheter and Surgical Treatment of Aortic Stenosis in England. Circ Cardiovasc Interv. 2021 May;14(5):e010413. doi: 10.1161/CIRCINTERVENTIONS.120.010413. 4. Gerdish M, La Meir M, McCarthy P, Ad N. Guest Editor Series Webinar: surgical atrial fibrillation – what we must do and what we can do. https://www.ctsnet.org/article/guest-editor-series-webinar-surgical-atrial-fibrillation-what-we-must-do-and-what-we-can-do

Douglas Drachman recaps his top takeaways from ACC 2021, and host Shelley Wood offers some highlights from EuroPCR.

Dr. Eliano Navarese, of Nicolaus Copernicus University, Poland, discusses the results of a meta-analysis comparing coronary revascularization vs. medical therapy alone. The study, presented as a late-breaking trial at EuroPCR 2021, showed that the benefits of both approaches are additive and that their combination is needed to attain maximal and lasting prevention of adverse events.

Dr. Bo Xu, of the Chinese Academy of Medical Sciences, discusses the results of the FUTURE-II trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, showed comparable safety and efficacy between the thin-strut Chinese Firesorb bioresorbable vascular scaffold and the cobalt-chromium everolimus-eluting Xience stents

Dr. Marko Noc, of University Medical Center in Slovenia, discusses the results of the COOL AMI EU pivotal trial with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, found longer randomization-to-balloon time and longer total ischemic time, as well as high rates of new-onset paroxysmal atrial fibrillation, for patients who received a therapeutic hypothermia device, the ZOLL Proteus Intra Vascular Temperature Management System, in patients presenting with acute ST-elevation myocardial infarction as compared to patients who did not receive the device.

Dr. David Hildick-Smith, of the Sussex Cardiac Centre, UK, discusses the results of the EBC MAIN study with Dr. Ron Waksman. The study, presented as a late-breaking trial at EuroPCR 2021, suggests no difference in 1-year clinical outcomes of a planned single-stent versus upfront two-stent strategy for true bifurcation distal left main disease.

This month features news from the latest spate of cardiology meetings: SCAI, EuroPCR, HRS, and more.

This month features news from the latest spate of cardiology meetings: SCAI, EuroPCR, HRS, and more.

Direto do EuroPCR 2019, o Dr Alexandre Quadros fala ao Podcast SBHCI, os últimos dados do Registro Latino Americano de Oclusão Crônica, em entrevista exclusiva ao Dr Antônio Fernando Diniz. Sigam, compartilhem e fiquem por dentro das novidades na cardiologia intervencionista.

Transcatheter aortic valves delivered better hemodynamic valve performance and less structural valve deterioration than surgical valves over 6 years. Transcatheter aortic valves outlast surgical valves in the NOTION study presented at EuroPCR. From Heart Rhythm 2018, a registry study suggests myocarditis is the culprit in many cases of frequent premature ventricular contractions, and one set of Botox shots into intracardiac fat pads cut atrial fibrillation for up to 3 years. Also this week, many patients with NAFLD and abnormal alanine aminotransferase should be taking a statin but aren’t, and why statins reduce the risk of lethal prostate cancer. Listen to Cardiocast weekly for all the latest cardiology news.

Welcome to the MDedge Cardiocast, the new weekly podcast from Cardiology News. We start with news from Paris, where EuroPCR saw noninvasive diagnostic methods defy accepted practice in patients with triple-vessel and stable coronary artery disease, as well as a resurrection of renal denervation for hypertension.

Entrevista exclusiva com Dr Pedro Lemos sobre o Bio-Resort, estudo randomizado para três stents de última geração - polímero durável com zotarolimus, polímero abluminal biabsorvível com everolimus e, stents com hastes muito finas com polímero circunferencial e sirolimus. Venha conhecer os resultados no PodCast da SBHCI!

Dr Alexandre Abizaid fala sobre os novos dispositivos vasculares bioabsorvíveis e o tempo de dupla antiagregação planetária diretamente do EuroPCR 2018. Não percam!

Ouça com exclusividade no Podcast da SBHCI a entrevista com o Dr Pedro Lemos, sobre os resultados em longo prazo do estudo NOTION, apresentados no EuroPCR 2018. Tal estudo comparou os achados clínicos e ecocardiográficos entre os pacientes submetidos à troca valvar cirúrgica e implante transvalvar percutâneo da valva aórtica.

On this week's Medtech Insight podcast: ex-US FDA Commissioner Bob Califf talks new commish and Trump; the latest on the Food and Drug Administration Reauthorization Act (FDARA); FDA recommends approval for the TransMedics Organ Care System; blood lead tests made by Magellan Diagnostics may give bad results; updates from the Heart Rhythm and EuroPCR meetings, held in Chicago and France, respectively.